PTC THERAPEUTICS, INC. — Director's Dealing 2021

Aug 17, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PTC THERAPEUTICS, INC. (PTCT)
CIK: 0001070081
Period of Report: 2021-08-13

Reporting Person: Okey Stephanie (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-08-13	Common Stock	S	1650	$40.057	Disposed	963	Direct

Footnotes

F1: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $40.05 to $40.06 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.